Mirena 52 MG systems
Ended Awarded Last action
- Contract number
- SPE2DR26FBYLR
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,126
Award facts
- Contract value 100% obligated
- $2,125.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $2,125.92 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for Mirena 52 mg contraceptive systems. The delivery order, issued on December 5, 2025, with an ultimate completion date of December 29, 2025, operates under a firm fixed-price structure with no set-aside designation. This award is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) established through the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical supply chain support to Department of Defense military healthcare facilities worldwide.
The PPV-G GEN V contract, awarded to DMS Pharmaceutical Group on November 13, 2025, carries a ceiling value of $499,999,999 and extends through December 31, 2036, encompassing a 30-month base period with three optional 30-month extensions. This overarching contract authorizes the Defense Logistics Agency to issue firm fixed-price delivery orders for a full range of pharmaceutical products, including branded and generic prescription medications, biologics, vaccines, and medical consumables. DMS Pharmaceutical Group's established performance across numerous prior delivery orders demonstrates its capability to fulfill specialized pharmaceutical requirements supporting the Department of Defense's global military medical operations.
Quick answers
Who was awarded contract SPE2DR26FBYLR?
SPE2DR26FBYLR was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 5, 2025.
How much is contract SPE2DR26FBYLR worth?
The government has obligated $2,126 on SPE2DR26FBYLR.
Is contract SPE2DR26FBYLR an order under another contract?
Yes. SPE2DR26FBYLR is a delivery order under SPE2DR25D9103, an indefinite delivery contract.
Was contract SPE2DR26FBYLR competed?
The extent of competition for SPE2DR26FBYLR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award